| |
Congratulations to our 2024 10 for 10 winner, Mélanie Lebel-Morin!
"Since 2023, I have been personally affected by bladder cancer, an experience that has impacted my life and transformed my perspective on this little-known disease. With conviction, I committed to the BCC 10 for 10 Campaign, an initiative that is especially close to my heart. Through this effort, I aimed not only to raise public awareness but also to support patients and contribute to funding research, essential for advancing treatments and hope."
Congratulations, Mélanie, on winning the $500 Visa gift card! We are immensely grateful to you, and to everyone who took part in BCC 10 for 10!
| | New Podcast: Susan's story of strength and resilience | |
When Susan’s bladder cancer journey began in 2012, she was not expecting it to take the path that it did. Over the course of 10 years, she had 45 rounds of BCG, 39 Cystoscopies, 8 surgeries, 4 rounds of intravesical chemotherapy - all over the course of
Interviewed by Summer Stewart, Susan’s story offers empowering advice on how to live life to the fullest despite any challenges you may face along the way.
| | Walk September 20th or 21st! | |
Register now and raise $150 towards your personal fundraising goal by April 30, 2025, to be entered to win a $400 Visa gift card.
Use promo code LACEEMUP25 to receive $10 off the registration fee, or kickstart your fundraising with a $100 self-donation to waive the $25 registration fee entirely!
| |
Tumor microenvironment transcriptional heterogeneity in neoadjuvant therapy response prediction in MIBC | |
Bladder cancer remains a challenging disease, especially for patients with muscle-invasive bladder cancer (MIBC) and metastatic urothelial carcinoma (mUC). Enfortumab Vedotin (EV), an antibody-drug conjugate, has shown promise, especially when combined with pembrolizumab, reducing cancer progression and mortality compared to chemotherapy. However, while many patients respond well initially, some experience treatment resistance, limiting its long-term effectiveness.
Dr. Peter Black and his team are leading a critical research project to better understand this resistance - why some bladder cancers stop responding to EV and pembrolizumab, and to develop tools that help predict which patients are most likely to benefit from this treatment.
| | |
|
Calling healthcare professionals! 📢
| |
Bladder Cancer Canada and Pfizer are excited to announce the third joint request for proposals (RFP) to support programs aimed at improving the quality of care of people living with bladder cancer and help reduce the gap in funding of high-priority research topics for patients, caregivers, and scientists.
We invite healthcare professionals from institutions across Canada to apply for the Pfizer RFP to help address the unmet needs of Canadians living with bladder cancer.
Apply now! Submission deadline is March 20.
| | |
| |
March 25th:
Join us for a live workout with Amy Sweeney!
During this session, Amy will lead us through simple exercises, designed specifically for the bladder cancer community.
| | |
April 23rd:
Join us for our guest speaker Trevor Smith-Miller!
Trevor will break down a recent report published by Canadian Cancer Society, explain what it means for patients and survivors, and outline the resources available to support you.
| | |
May 27th:
Join us for our guest speaker Dr. Madhuri Koti!
During this session, Dr.Koti will examine how aging and sex differences influence risk, diagnosis, treatment, and outcomes for bladder cancer patients.
| |
|
Bladder Cancer Canada is thrilled to be hosting a FREE, in-person event in Vancouver on May 14th, bringing together bladder cancer patients, caregivers, advocates and healthcare professionals.
This event is an opportunity to hear presentations from Dr. Peter Black and Dr. Bernie Eigl, connect with the local community members, explore key topics in bladder cancer care, and engage in meaningful discussion. Don't miss out on the chance to gain valuable insights and be part of a supportive, informative gathering.
Space is limited, so be sure to register early!
| | | | For all upcoming events, webinars and support group meetings, visit our Event Page | | The NEW Urinary Diversion Support Group is just days away! | |
Hosted by nurses Cindy Brown & Juliana Cozza dos Santos, this group is open to anyone with questions about urostomies/ileal conduits, neobladders, or Indiana pouches.
The virtual support group will kick off on Thursday, March 20 at 7pm ET, and will continue to meet on the third Thursday of every month thereafter.
To join this group, or if you are looking for more information, please email: diversionsupport@bladdercancercanada.org.
| | |
Role: Walk Lead
Fun fact about me: I enjoy swimming and bicycling. Last summer I was a cycling instructor teaching safe cycling to kids and adults.
Why are you passionate about volunteering for BCC: I am passionate about volunteering with BCC because not only are we raising funds for research and awareness but BCC also offers guidance to patients. Being diagnosed with bladder cancer is a sudden shock that leaves many patients feeling lost or hopeless but by using the information guides, One2One support, support groups or the discussion forum, patients can feel confident on their route to recovery.
Interested in volunteering with BCC?
| |
Follow us online
Please join us on social media where we share updates and photos from our bladder cancer community. These social media sites are a great resource for patients, survivors, and caregivers.
| | |
Copyright © 2025 Bladder Cancer Canada. All rights reserved. You are receiving this email because you have registered on our website or expressed an interest in receiving more information about bladder cancer or Bladder Cancer Canada. |
| | | |
